Health
Heart Transplant ‘Liquid Biopsy’; PCSK9 CRISPR; More SGLT2 Drugs Try FDA in HF – MedPage Today
Recent developments of interest in cardiovascular medicine
A blood test showed promise as a “liquid biopsy” for detection of acute heart transplant rejection. (Circulation)
Early efforts to use CRISPR to edit PCSK9 genes in severe heterozygous familial hypercholesterolemia are moving forward. (Endpoints News)
In a study of 145 student athletes with no more than moderate COVID-19 symptoms, cardiac MRI a median 15 days after the positive test was consistent with myocarditis in two (1.4%). (JAMA Cardiology)
Each extra serving of fried foods per week was linked…
-
General24 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News23 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Noosa News19 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
General23 hours agoIranian supreme leader makes first public appearance since war with Israel